2016 went out like a lamb in the biopharma M&A world. Will it roar back in 2017? Plus, top 10 deals

2016 went out like a lamb in the biopharma M&A world. Will it roar back in 2017? Plus, top 10 deals

Submitted by admin on February 22, 2017 - 11:43am
Source: 
Endpoints
News Tags: 
M&A
Shire
Baxalta
Pfizer
Medivation
Mylan
Meda
AbbVie
Stemcentrx
Anacor
Headline: 
2016 went out like a lamb in the biopharma M&A world. Will it roar back in 2017? Plus, top 10 deals

Do Not Allow Advertisers to Use My Personal information